Results 151 to 160 of about 51,867 (216)

Pharmacotherapy of Duchenne Muscular Dystrophy (DMD)

open access: yes
Duchenne Muscular Dystrophy (DMD) is a severe, progressive neuromuscular disorder caused by mutations in the DMD gene, leading to the absence of functional dystrophin protein.
Poornachandran, Deepti Nirja
core  

Enfermedades genéticas: distrofia muscular de Duchenne

open access: yesRevista de Medicina y Cine / Journal of Medicine and Movies, 2016
María GARCÍA MORO   +2 more
doaj  

Functional electrical stimulation for major depressive disorder: Protocol for a pilot randomized controlled trial. [PDF]

open access: yesPLoS One
Gholamali Nezhad F   +12 more
europepmc   +1 more source

Characterization of Dystrophin-Related Syndromes: Carriers, DMD, and BMD. [PDF]

open access: yesMuscles
Chabbi N   +4 more
europepmc   +1 more source

Echocardiography in duchenne muscular dystrophy: a call for consistency and standardisation of reporting. [PDF]

open access: yesEcho Res Pract
Williams L   +20 more
europepmc   +1 more source

Current and prospective treatment of Duchenne Muscular Dystrophy

open access: yes
Duchenne muscular dystrophy (DMD) is a serious condition of genetic origin that is passed down in the X-linked manner and that mainly afflicts boys. It is the result of a steady muscle tissue degeneration caused by mutations in the dystrophin gene on the
Rodriguez, Isaac
core  

Emerging Therapies in Duchenne Muscular Dystrophy: A Comparative Analysis of Gene Therapy and Pharmacological Approaches

open access: yes
Duchenne muscular dystrophy (DMD) is a progressive and severe X-linked recessive disorder characterized by progressive muscle weakness due to degeneration of muscle fibers resulting in a shortened life span.
Ninsiima , Karen Tukahirwa Jessica
core  

Home - About - Disclaimer - Privacy